Tags

Type your tag names separated by a space and hit enter

Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria.
J Allergy Clin Immunol. 2007 Mar; 119(3):705-10.JA

Abstract

BACKGROUND

In patients with chronic urticaria (CU), plasma shows signs of thrombin generation and autologous plasma skin tests score positive in as many as 95% of cases.

OBJECTIVE

To evaluate the initiators of blood coagulation that lead to thrombin generation and fibrinolysis in CU.

METHODS

Activated factor VII, activated factor XII, fragment F(1+2), and D-dimer plasma levels were measured in 37 patients with CU and 37 controls. Skin specimens from 10 patients with CU and 10 controls were tested for tissue factor immunohistochemically.

RESULTS

Mean F(1+2) levels were higher in patients than controls (2.54 [SD 2.57] nmol/L vs 0.87 [0.26] nmol/L; P < .001); disease activity was moderate or severe in 9 of 11 (82%) and 9 of 26 (35%) patients showing high or normal F(1+2) levels, respectively (P < .025). Mean D-dimer plasma levels were higher in patients than controls (329 [188] ng/mL vs 236 [81] ng/mL; P < .01); disease activity was moderate or severe in 6 of 8 (75%) and 11 of 29 (38%) showing elevated or normal plasma D-dimer levels (P = NS). Factor VIIa levels were higher in patients than controls (2.86 ng/mL [0.66] vs 1.97 ng/mL [0.65]; P < .001). Activated factor VII and F(1+2) levels were correlated (r = 0.529; P = .008). Tissue factor reactivity was observed only in CU skin specimens.

CONCLUSION

The extrinsic pathway of clotting cascade is activated in CU. Disease severity is associated with the activation of the coagulation cascade.

CLINICAL IMPLICATIONS

The involvement of the coagulation pathway in CU opens new perspectives for a better understanding of the pathogenesis and, possibly, for the treatment of this disease.

Authors+Show Affiliations

Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, Italy. r.asero@libero.itNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17204316

Citation

Asero, Riccardo, et al. "Activation of the Tissue Factor Pathway of Blood Coagulation in Patients With Chronic Urticaria." The Journal of Allergy and Clinical Immunology, vol. 119, no. 3, 2007, pp. 705-10.
Asero R, Tedeschi A, Coppola R, et al. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol. 2007;119(3):705-10.
Asero, R., Tedeschi, A., Coppola, R., Griffini, S., Paparella, P., Riboldi, P., Marzano, A. V., Fanoni, D., & Cugno, M. (2007). Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. The Journal of Allergy and Clinical Immunology, 119(3), 705-10.
Asero R, et al. Activation of the Tissue Factor Pathway of Blood Coagulation in Patients With Chronic Urticaria. J Allergy Clin Immunol. 2007;119(3):705-10. PubMed PMID: 17204316.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. AU - Asero,Riccardo, AU - Tedeschi,Alberto, AU - Coppola,Raffaella, AU - Griffini,Samantha, AU - Paparella,Paolo, AU - Riboldi,Piersandro, AU - Marzano,Angelo V, AU - Fanoni,Daniele, AU - Cugno,Massimo, Y1 - 2007/01/03/ PY - 2006/05/19/received PY - 2006/08/30/revised PY - 2006/08/30/accepted PY - 2007/1/6/pubmed PY - 2007/4/14/medline PY - 2007/1/6/entrez SP - 705 EP - 10 JF - The Journal of allergy and clinical immunology JO - J Allergy Clin Immunol VL - 119 IS - 3 N2 - BACKGROUND: In patients with chronic urticaria (CU), plasma shows signs of thrombin generation and autologous plasma skin tests score positive in as many as 95% of cases. OBJECTIVE: To evaluate the initiators of blood coagulation that lead to thrombin generation and fibrinolysis in CU. METHODS: Activated factor VII, activated factor XII, fragment F(1+2), and D-dimer plasma levels were measured in 37 patients with CU and 37 controls. Skin specimens from 10 patients with CU and 10 controls were tested for tissue factor immunohistochemically. RESULTS: Mean F(1+2) levels were higher in patients than controls (2.54 [SD 2.57] nmol/L vs 0.87 [0.26] nmol/L; P < .001); disease activity was moderate or severe in 9 of 11 (82%) and 9 of 26 (35%) patients showing high or normal F(1+2) levels, respectively (P < .025). Mean D-dimer plasma levels were higher in patients than controls (329 [188] ng/mL vs 236 [81] ng/mL; P < .01); disease activity was moderate or severe in 6 of 8 (75%) and 11 of 29 (38%) showing elevated or normal plasma D-dimer levels (P = NS). Factor VIIa levels were higher in patients than controls (2.86 ng/mL [0.66] vs 1.97 ng/mL [0.65]; P < .001). Activated factor VII and F(1+2) levels were correlated (r = 0.529; P = .008). Tissue factor reactivity was observed only in CU skin specimens. CONCLUSION: The extrinsic pathway of clotting cascade is activated in CU. Disease severity is associated with the activation of the coagulation cascade. CLINICAL IMPLICATIONS: The involvement of the coagulation pathway in CU opens new perspectives for a better understanding of the pathogenesis and, possibly, for the treatment of this disease. SN - 0091-6749 UR - https://www.unboundmedicine.com/medline/citation/17204316/Activation_of_the_tissue_factor_pathway_of_blood_coagulation_in_patients_with_chronic_urticaria_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0091-6749(06)02354-2 DB - PRIME DP - Unbound Medicine ER -